Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | HTR7 | P34969 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.30 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.30 |
| ▸ | HTR1D | P28221 | 1/20 | 0.30 |
| ▸ | HTR1B | P28222 | 1/20 | 0.30 |
| ▸ | HTR6 | P50406 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21982468 | 0.92 | PTGS2 (0.33) | PTGS2KMT2AATMHTR1AHTR7 | |
| SCHEMBL20172930 | 0.89 | HTR1A (0.35) | PTGS2KMT2AHTR1AHTR7HRH3 | |
| SCHEMBL20172914 | 0.87 | PTGS2 (0.31) | PTGS2HTR1AHTR7 | |
| SCHEMBL20172883 | 0.85 | HTR2C (0.33) | PTGS2HTR1AHTR7HRH3ADRA2A | |
| SCHEMBL20172894 | 0.84 | SLC6A4 (0.32) | PTGS2KMT2AHTR1AHTR7ADRA2A | |
| SCHEMBL20172869 | 0.84 | ABCC1 (0.33) | PTGS2KMT2AHTR1AHTR7HRH3 | |
| SCHEMBL20172925 | 0.84 | HTR2C (0.36) | PTGS2HTR1AHTR7 | |
| SCHEMBL21021045 | 0.82 | ADRA2A (0.34) | HTR1AHTR7HRH3ADRA2AADRA2B | |
| SCHEMBL21021483 | 0.82 | HTR1D (0.34) | PTGS2KMT2AHTR1AHTR7HRH3 | |
| SCHEMBL20172941 | 0.82 | ADRA2A (0.32) | HTR1AHTR7HRH3ADRA2AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10651411-B2 | Compound and organic light emitting device containing same | LG CHEM, LTD. (KR) | 2020-05-12 | — | — | US | disclosed |
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | CRY1, CRY2, OR10J3 | PTGS2 2509/4885KMT2A 517/4885ATM 2781/4885 |
| US-10651411-B2 | Compound and organic light emitting device containing same | CRY1, CRY2, OR10J3 | PTGS2 2509/4885KMT2A 517/4885ATM 2781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.